LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – Regeneron Pharmaceuticals, Inc. Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$8.22M
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +8.44% | 929 shares | 1.71M | $688.87 | 11.93K |
| Q2 2022 | share | Increase | +0.84% | 92 shares | -1.11M | $591.13 | 11.00K |
| Q1 2022 | share | Increase | +0.65% | 71 shares | 775K | $698.42 | 10.91K |
| Q4 2021 | share | Increase | +1.26% | 135 shares | 367K | $642.51 | 10.84K |
| Q3 2021 | share | Increase | +0.21% | 22 shares | 512K | $605.18 | 10.70K |
| Q2 2021 | share | Increase | +5.43% | 550 shares | 1.17M | $558.54 | 10.68K |
| Q1 2021 | share | Increase | +6234.38% | 9.97K shares | 4.71M | $473.14 | 10.13K |
| Q4 2020 | share | Increase | 0.00% | 160 shares | 77K | $483.11 | 160 |
| Q2 2018 | share | Decrease | -100.00% | -345 shares | -119K | $344.99 | 0 |
| Q1 2018 | share | Decrease | -53.69% | -400 shares | -161K | $344.36 | 345 |
| Q4 2017 | share | 0.00% | 0 shares | -53K | $375.96 | 745 | |
| Q3 2017 | share | Increase | +204.08% | 500 shares | 213K | $447.12 | 745 |
| Q2 2017 | share | 0.00% | 0 shares | 25K | $491.14 | 245 | |
| Q1 2017 | share | 0.00% | 0 shares | 5K | $387.51 | 245 | |
| Q4 2016 | share | 0.00% | 0 shares | -8K | $367.09 | 245 | |
| Q3 2016 | share | 0.00% | 0 shares | 12K | $402.02 | 245 | |
| Q2 2016 | share | 0.00% | 0 shares | -2K | $349.23 | 245 | |
| Q1 2016 | share | 0.00% | 0 shares | -45K | $360.44 | 245 |